down arrow

Valiant Laborato

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0JWS01017
  • NSEID: VALIANTLAB
  • BSEID: 543998
INR
70.45
5.36 (8.23%)
BSENSE

Dec 05

BSE+NSE Vol: 3.23 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Valiant Laboratories Ltd stock-summary
stock-summary
Valiant Laboratories Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Valiant Laboratories Limited was originally formed as a Partnership Firm under the name and style of `M/s. Bharat Chemicals' through Deed of Partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Limited Company with the name "Valiant Laboratories Limited" through certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 54.31 Cr
Number of Shares
5.43 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
18-Jul-2025
5.43
54.31
10862500
10
Right Issues
04-Oct-2023
4.34
43.45
10890000
10
Public Issue
23-Feb-2023
3.26
32.56
16280000
10
Bonus Issue
28-Mar-2022
1.63
16.28
1480000
10
Bonus Issue
06-Feb-2022
1.48
14.80
4300000
10
Right Issues
16-Aug-2021
1.05
10.50
10500000
10
Subscriber to MOA
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (0.02%)

Promoter with highest holding

Dhanvallabh Ventures Llp (46.84%)

Highest Public shareholder

None

Individual Investors Holdings

18.19%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Velji Gogri
Chairman & Independent Directo
50.0 k
Santosh S. Vora
Managing Director
12.0 lacs
Shantilal Shivji Vora
Director
14.8 lacs
Paresh Shashikant Shah
Executive Director
15.0 lacs
Sonal A Vira
Independent Director
50.0 k
Sandeep Gupta..
Addtnl Non-Executive Director
0
Saloni Mehta
Company Sec. & Compli. Officer
4.3 lacs
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchases of Stock in Trade
0.5614
0%
 
100
Purchases of Stock in Trade
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
46 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 354 Cr (Micro Cap)

stock-summary
P/E

69.00

stock-summary
Industry P/E

34

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.03

stock-summary
Return on Equity

1.60%

stock-summary
Price to Book

1.10

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."